December 15, 2015 / 1:56 PM / in 2 years

BRIEF-Valeant CEO says will get back to acquisitions - but not next year

Dec 15 (Reuters) - Valeant Pharmaceuticals International Inc

* CEO says will get back to acquisitions, but not next year, when it will focus on paying down debt instead - CNBC

* CEO says will spend 7 to 8 percent of sales on research and development in 2016 - about half the level of typical big pharma companies and up from previous spending - CNBC

* CEO says will spend $400 to $500 million on R&D (Reporting By Caroline Humer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below